Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
Bipolar disorders
Nature Reviews Disease Primers, Volume 4, Article 18008, Year 2018
Notification
URL copied to clipboard!
Description
Bipolar disorders are chronic and recurrent disorders that affect >1% of the global population. Bipolar disorders are leading causes of disability in young people as they can lead to cognitive and functional impairment and increased mortality, particularly from suicide and cardiovascular disease. Psychiatric and nonpsychiatric medical comorbidities are common in patients and might also contribute to increased mortality. Bipolar disorders are some of the most heritable psychiatric disorders, although a model with gene-environment interactions is believed to best explain the aetiology. Early and accurate diagnosis is difficult in clinical practice as the onset of bipolar disorder is commonly characterized by nonspecific symptoms, mood lability or a depressive episode, which can be similar in presentation to unipolar depression. Moreover, patients and their families do not always understand the significance of their symptoms, especially with hypomanic or manic symptoms. As specific biomarkers for bipolar disorders are not yet available, careful clinical assessment remains the cornerstone of diagnosis. The detection of hypomanic symptoms and longtudinal clinical assessment are crucial to differentiate a bipolar disorder from other conditions. Optimal early treatment of patients with evidence-based medication (typically mood stabilizers and antipsychotics) and psychosocial strategies is necessary. © 2018 Macmillan Publishers Limited, part of Springer Natur.
Authors & Co-Authors
Vieta, Eduard
Spain, Barcelona
Hospital Clinic Barcelona
Berk, Michael
Australia, Geelong
Deakin University
Australia, Melbourne
Centre for Youth Mental Health
Australia, Melbourne
The Florey
Schulze, Thomas S. G.
Germany, Munich
Klinikum Der Universität München
Germany, Gottingen
Georg-august-universität Göttingen
United States, Bethesda
Instituto Nacional de la Salud Mental
United States, Baltimore
Johns Hopkins University
Germany, Mannheim
Zentralinstitut Für Seelische Gesundheit
Carvalho, André F.
Canada, Toronto
University of Toronto
Canada, Toronto
Centre for Addiction and Mental Health
Calabrese, Joseph R.
United States, Cleveland
Case Western Reserve University
United States, Cleveland
University Hospitals Case Medical Center
Miskowiak, Kamilla Woznica
Denmark, Copenhagen
Copenhagen University Hospital
Denmark, Copenhagen
Københavns Universitet
Statistics
Citations: 193
Authors: 6
Affiliations: 17
Identifiers
Doi:
10.1038/nrdp.2018.8
ISSN:
2056676X
Research Areas
Disability
Genetics And Genomics
Mental Health
Noncommunicable Diseases
Study Design
Cross Sectional Study